Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer
Clinical trial NCT03025867 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03025867
- Sponsor
- Tesaro, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.